Global burden of disease in young people aged 10-24 years: a systematic analysis, Lancet, vol.377, issue.9783, pp.2093-2102, 2011. ,
Scientific Advisory Board and the Executive Committee of the Grand Challenges on Global Mental Health, Nature, vol.475, issue.7354, pp.27-30, 2011. ,
Lithium in the treatment of mood disorders, N Engl J Med, vol.331, issue.9, pp.591-598, 1994. ,
Nonresponse to reinstituted lithium prophylaxis in previously responsive bipolar patients: prevalence and predictors, Am J Psychiatry, vol.152, issue.12, pp.1810-1811, 1995. ,
Anticonvulsants and suicide attempts in bipolar I disorders, Acta Psychiatr Scand, vol.135, issue.5, pp.470-478, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01783781
Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations, CNS Drugs, vol.25, issue.4, pp.289-298, 2011. ,
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update, Bipolar Disord, vol.15, issue.1, pp.1-44, 2013. ,
Serum levels and pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients during chronic dosage, Int J Clin Pharmacol Ther Toxicol, vol.24, issue.5, pp.257-261, 1986. ,
Serum level monitoring and clinical pharmacokinetics of lithium, Clin Pharmacokinet, vol.2, issue.2, pp.73-92, 1977. ,
Evaluation of a slow-release lithium carbonate formulation, Am J Psychiatry, vol.135, issue.8, pp.917-922, 1978. ,
Lithium in bipolar disorder: can drug concentrations predict therapeutic effect?, Clin Pharmacokinet, vol.41, issue.9, pp.639-660, 2002. ,
, Résumé des Caractéristiques du Produit, p.2017
Differential pharmacokinetics of lithium in elderly patients, Drugs Aging, vol.16, issue.3, pp.165-177, 2000. ,
Lithium: updated human knowledge using an evidence-based approach. Part II: clinical pharmacology and therapeutic monitoring, CNS Drugs, vol.23, issue.4, pp.331-349, 2009. ,
The pharmacokinetics of lithium, The science and practice of lithium therapy, 2017. ,
, , pp.25-53
Gabapentin does not alter single-dose lithium pharmacokinetics, J Clin Psychopharmacol, vol.18, issue.6, pp.461-464, 1998. ,
Single dose pharmacokinetic study of lithium in Taiwanese/Chinese bipolar patients, Aust N Z J Psychiatry, vol.32, issue.1, pp.133-136, 1998. ,
Pharmacokinetics of ordinary and sustainedrelease lithium carbonate in manic patients after acute dosage, Eur J Clin Pharmacol, vol.14, issue.4, pp.267-271, 1978. ,
Clinical pharmacokinetics of lithium, J Clin Pharmacol, vol.34, issue.4, pp.280-285, 1994. ,
Nonparametric estimation of population characteristics of the kinetics of lithium from observational and experimental data: individualization of chronic dosing regimen using a new Bayesian approach, Ther Drug Monit, vol.16, issue.3, pp.258-269, 1994. ,
Single dose pharmacokinetics of lithium & prediction of maintenance dose in manic depressive patients, Indian J Med Res, vol.92, pp.409-416, 1990. ,
Maintenance lithium levels could be lowered: based on Taiwanese and Danish studies, J Formos Med Assoc, vol.90, issue.5, pp.509-513, 1991. ,
Lithium population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens, Ther Drug Monit, vol.15, issue.2, pp.75-82, 1993. ,
Population pharmacokinetic analyses of lithium: a systematic review, Eur J Drug Metab Pharmacokinet, vol.43, issue.1, pp.25-34, 2018. ,
Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population pharmacokinetic approach, Int J Clin Pharmacol Ther, vol.46, issue.12, pp.617-626, 2008. ,
A computerised sampling strategy for therapeutic drug monitoring of lithium provides precise estimates and significantly reduces dose-finding time, Basic Clin Pharmacol Toxicol, vol.110, issue.3, pp.259-263, 2012. ,
Pharmacokinetics of lithium in plasma and red blood cells in acute and chronic intoxicated patients, Int J Clin Pharmacol Ther, vol.33, issue.6, pp.351-355, 1995. ,
Erythrocyte lithium-sodium countertransport and total body lithium pharmacokinetics in patients with affective illness, Hum Psychopharmacol Clin Exp, vol.3, issue.2, pp.87-93, 1988. ,
The relationship of plasma to erythrocyte lithium levels in patients taking lithium carbonate, Br J Psychiatry, vol.127, pp.596-598, 1975. ,
Relationship between plasma, RBC, and CSF lithium concentrations in human subjects, Int Pharmacopsychiatry, vol.14, issue.4, pp.185-189, 1979. ,
The relationship of the lithium erythrocyte: plasma ratio to plasma lithium level, Biol Psychiatry, vol.14, issue.1, pp.207-213, 1979. ,
The impact of compliance in pharmacokinetic studies, Stat Methods Med Res, vol.8, issue.3, pp.247-262, 1999. ,
Correlations between objective and subjective sleep and circadian markers in remitted patients with bipolar disorder, Chronobiol Int, vol.31, issue.5, pp.698-704, 2014. ,
Is response to prophylactic lithium a familial trait?, J Clin Psychiatry, vol.63, issue.10, pp.942-947, 2002. ,
Maximum likelihood estimation in nonlinear mixed effects models, Comput Stat Data Anal, vol.49, issue.4, pp.1020-1038, 2005. ,
Prediction model of serum lithium concentrations, Pharmacopsychiatry, vol.51, issue.3, pp.82-88, 2018. ,
Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers, Eur J Clin Pharmacol, vol.61, issue.2, pp.103-111, 2005. ,
Model evaluation of continuous data pharmacometric models: metrics and graphics, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01484967
Importance of shrinkage in empirical Bayes estimates for diagnostics: problems and solutions, AAPS J, vol.11, issue.3, pp.558-569, 2009. ,
dOFV distributions: a new diagnostic for the adequacy of parameter uncertainty in nonlinear mixed-effects models applied to the bootstrap, J Pharmacokinet Pharmacodyn, vol.43, issue.6, pp.597-608, 2016. ,
Steady-state pharmacokinetics of lithium carbonate in healthy subjects, Br J Clin Pharmacol, vol.25, issue.3, pp.375-380, 1988. ,
Pharmacokinetics of lithium preparations in patients, Prog Neuro-Psychopharmacol Biol Psychiatry, vol.8, issue.1, pp.63-70, 1984. ,
Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acuteon-chronic toxicity, Eur J Clin Pharmacol, vol.59, issue.8-9, pp.583-587, 2003. ,
Lithium distribution in mania: single-dose pharmacokinetics and sympathoadrenal function, Psychiatry Res, vol.32, issue.1, pp.71-84, 1990. ,
A study of the transport of lithium across the erythrocyte membrane in vivo and of the effects of the ion transport inhibitors digoxin and dipyridamole, Br J Clin Pharmacol, vol.27, issue.6, pp.749-756, 1989. ,
Serum lithium concentrations around the clock with different treatment regimens and the diurnal variation of the renal lithium clearance, Acta Psychiatr Scand, vol.64, issue.4, pp.314-319, 1981. ,
Lithium treatments: single and multiple daily dosing, Clinical pharmacokinetics. ASHP, 433 p 48, vol.53, pp.323-331, 2008. ,
Population pharmacokinetic analysis of circadian rhythms in hepatic CYP3A activity using midazolam, J Clin Pharmacol, vol.54, issue.10, pp.1162-1169, 2014. ,
Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African children, J Antimicrob Chemother, vol.72, issue.1, pp.190-199, 2017. ,
Identifying 24 h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach, Br J Clin Pharmacol, vol.81, issue.2, pp.256-268, 2016. ,